Research output per year
Research output per year
Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/16 → 31/12/20 |
Funding
- National Health and Medical Research Council (NHMRC) (Australia): A$467,960.50
-
Advanced prostate cancer experimental radioactive treatment-clinical trial decision making: Patient experiences
Viljoen, B., Hofman, M. S., Chambers, S. K., Dunn, J., Dhillon, H., Davis, I. D. & Ralph, N., Nov 2024, In: BMJ Supportive & Palliative Care. 14, e2, p. e2177-e2183 7 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP
Stockler, M. R., Martin, A. J., Davis, I. D., Dhillon, H. M., Begbie, S. D., Chi, K. N., Chowdhury, S., Coskinas, X., Frydenberg, M., Hague, W. E., Horvath, L. G., Joshua, A. M., Lawrence, N. J., Marx, G. M., McCaffrey, J., McDermott, R., McJannett, M., North, S. A., Parnis, F. & Parulekar, W. R. & 14 others, , 10 Mar 2022, In: Journal of Clinical Oncology. 40, 8, p. 837-846 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access33 Citations (Scopus) -
Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial
Soo, W. K., King, M. T., Pope, A., Parente, P., Dārziņš, P. & Davis, I. D., Sept 2022, In: The Lancet Healthy Longevity. 3, 9, p. e617-e627 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access100 Citations (Scopus)